We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

165 hedge funds and large institutions have $1.03B invested in DIPLOMAT PHARMACY, INC. in 2017 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 77 increasing their positions, 42 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

228% more call options, than puts

Call options by funds: $2.1M | Put options by funds: $641K

83% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 42

45% more capital invested

Capital invested by funds: $706M → $1.03B (+$319M)

6% less funds holding

Funds holding: 175165 (-10)

25% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 28

Holders
165
Holders Change
-10
Holders Change %
-5.71%
% of All Funds
4.11%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
21
Increased
77
Reduced
42
Closed
28
Calls
$2.1M
Puts
$641K
Net Calls
+$1.46M
Net Calls Change
+$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
BA
26
Broadview Advisors
Wisconsin
$9.15M -$74.8K -4,425 -1%
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$8.23M +$6.72M +397,200 New
TCIM
28
TIAA CREF Investment Management
New York
$7.81M -$48.3K -2,857 -0.8%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$7.62M -$219K -12,952 -3%
Deutsche Bank
30
Deutsche Bank
Germany
$7.62M +$1.48M +87,344 +31%
Principal Financial Group
31
Principal Financial Group
Iowa
$7.47M +$479K +28,343 +9%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$6.79M -$1.07M -63,004 -16%
TA
33
Teachers Advisors
New York
$6.12M -$26.3K -1,556 -0.5%
Charles Schwab
34
Charles Schwab
California
$6.1M +$1.09M +64,484 +28%
Ameriprise
35
Ameriprise
Minnesota
$5.53M -$102K -6,050 -2%
State of Wisconsin Investment Board
36
State of Wisconsin Investment Board
Wisconsin
$4.72M -$845K -50,000 -18%
PP
37
PDT Partners
New York
$4.71M +$1.97M +116,606 +105%
DZ Bank
38
DZ Bank
Germany
$4.14M +$3.38M +200,000 New
Balyasny Asset Management
39
Balyasny Asset Management
Illinois
$4.08M -$10.8M -640,279 -76%
Goldman Sachs
40
Goldman Sachs
New York
$4.05M +$1.04M +61,536 +46%
Invesco
41
Invesco
Georgia
$3.9M +$193K +11,390 +6%
CCI
42
Columbus Circle Investors
$3.63M +$2.96M +175,336 New
GC
43
Guggenheim Capital
Illinois
$3.59M +$497K +29,390 +20%
T. Rowe Price Associates
44
T. Rowe Price Associates
Maryland
$3.48M +$342K +20,200 +14%
O
45
OppenheimerFunds
New York
$3.38M -$327K -19,326 -11%
NFA
46
Nationwide Fund Advisors
Ohio
$3.24M +$841K +49,749 +47%
VIA
47
Vident Investment Advisory
Georgia
$2.93M +$2.39M +141,308 New
Citigroup
48
Citigroup
New York
$2.58M -$1.31M -77,461 -38%
Barclays
49
Barclays
United Kingdom
$2.51M -$203K -11,993 -9%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$2.33M +$1.01M +59,714 +113%

DPLO Hedge Fund Activity: Q3 2017 in Review

165 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q3 2017, worth a combined $1.03B — up 45% from $706M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of DPLO and 21 opened new positions — a net loss of 7 holders — while 42 trimmed existing stakes and 77 added.

The largest buyer was Cortina Asset Management, adding an estimated $23.1M. The largest seller was Frontier Capital Management, cutting an estimated $27.7M.

  • 165 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q3 2017, down from 175 in Q2 2017.
  • Funds reported $1.03B of DIPLOMAT PHARMACY, INC. stock for Q3 2017, up 45% quarter-over-quarter.
  • 21 funds opened new DIPLOMAT PHARMACY, INC. positions in Q3 2017 and 28 closed out, a net change of -7 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q3 2017 was Cortina Asset Management, an estimated $23.1M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q3 2017 was Frontier Capital Management, an estimated $27.7M sold.

Based on aggregated 13F filings for Q3 2017.